Mangiferin-loaded smart gels for hsv-1 treatment

Abstract

Infections due to HSV-1 affect many people all over the world. To counteract this pathol-ogy, usually characterized by perioral sores or by less frequent serious symptoms including kerati-tis, synthetic antiviral drugs are employed, such as acyclovir, often resulting in resistant viral strains under long-term use. Many plant-derived compounds, such as mangiferin and quercetin, have demonstrated antiviral potentials. In this study, smart semisolid forms based on phosphatidylcho-line and Pluronic were investigated as delivery systems to administer mangiferin on skin and mu-cosae affected by HSV-1 infection. Particularly, lecithin organogels, Pluronic gel, and Pluronic lecithin organogels were formulated and characterized. After the selection of gel compositions, physical aspects, such as rheological behavior, spreadability, leakage, and adhesion were evaluated, suggest-ing a scarce suitability of the lecithin organogel for topical administration. Mangiferin was effi-ciently included in all type of gels. An in vitro study based on the Franz cell enabled us to find evidence of the gel capability to control drug diffusion, especially in the case of Pluronic organogel, while an in vivo study conducted on human volunteers demonstrated the safeness of all of the gels after cutaneous administration. Furthermore, a plaque reduction assay demonstrated the virucidal effect of mangiferin loaded in a Pluronic gel and a Pluronic lecithin organogel against the HSV-1 KOS strain.